Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/07/2011CN101506181B 三环化合物及其制药用途 Tricyclic compounds and their pharmaceutical use
12/07/2011CN101501008B 芳基哌嗪衍生物及其用途 Aryl piperazine derivatives and their use
12/07/2011CN101500580B 具有增强的Th-1模式的C-糖脂 C- glycolipids having enhanced Th-1 mode
12/07/2011CN101492489B 银莲花素a的提取方法及其脂微球制剂的制备方法 Raddeanin a method of extracting and preparing method Lipo preparations
12/07/2011CN101479278B 新型4-氨基-3-(吡咯基-苯氧基甲基)-噻吩并[3,2]吡啶-7-羧酸衍生物 Novel 4-amino-3- (pyrrolidin-yl - phenoxymethyl) - thieno [3,2] pyridine-7-carboxylic acid derivative
12/07/2011CN101455748B 一种消炎生肌药及其制备方法 Myogenic an anti - inflammatory drug and its preparation method
12/07/2011CN101448828B 作为烟碱性乙酰胆碱受体激动剂的3-杂芳基-3,9-二氮杂双环[3.3.1]壬烷衍生物 As the nicotinic acetylcholine receptor agonist 3-heteroaryl-3,9-diazabicyclo [3.3.1] nonane derivatives
12/07/2011CN101434573B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
12/07/2011CN101396343B 以脂质复合物为中间载体的紫杉醇亚微乳 Lipid complexes for intermediate vector paclitaxel submicroemulsion
12/07/2011CN101389610B 作为香草素受体1(vr1)抑制剂的新苯并咪唑衍生物 As vanilloid receptor 1 (vr1) inhibitors new benzimidazole derivatives
12/07/2011CN101384261B 治疗疼痛的组合物 The therapeutic composition of pain
12/07/2011CN101357893B 乙二胺类金属蛋白酶抑制剂及其应用 Ethylenediamines metalloproteinase inhibitor and its application
12/07/2011CN101357117B 灯盏花素注射液及其制备方法 Breviscapine injection and its preparation method
12/07/2011CN101348509B 2-芳基-6-芳基'-葡萄糖苷类化合物及其制备方法与应用 2-aryl-6-aryl '- glucoside compound and its preparation method and application
12/07/2011CN101340919B 治疗艰难梭菌相关的腹泻的方法 Method of treating C. difficile associated diarrhea
12/07/2011CN101336637B 一种复合型广谱消毒剂及应用 A composite type and application of broad-spectrum disinfectant
12/07/2011CN101300235B 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物 As p2x3 and diamino pyrimidine derivatives p2x2 / 3 modifier
12/07/2011CN101293899B 无环核苷膦酸酯衍生物及其医药用途 Acyclic nucleoside phosphonate derivatives and pharmaceutical use
12/07/2011CN101292965B 一种类β-胡萝卜素微囊及其制备方法 One kind of class β- carotene microcapsules and its preparation method
12/07/2011CN101279011B 可快速恢复体力的营养剂 Quickly recuperate nutrients
12/07/2011CN101269102B 用于优生优育预防出生缺陷和改善记忆的药物组合物 Prenatal and postnatal care for the prevention of birth defects and improve memory pharmaceutical compositions
12/07/2011CN101253159B 作为P2X<sub>3</sub>和P2X<sub>2/3</sub>调节剂的二氨基嘧啶类化合物 As P2X <sub> 3 </ sub> and diaminopyrimidines P2X <sub> 2/3 </ sub> modifier compounds
12/07/2011CN101232901B 磺酰胺化合物和血管生成抑制物质的联合新应用 Sulfonamide compound and angiogenesis inhibitory substances combined new applications
12/07/2011CN101229258B 抗过敏消炎膏 Allergy-inflammatory cream
12/07/2011CN101175724B 吡咯烷衍生物或其盐 Pyrrolidine derivative or a salt thereof
12/07/2011CN101163479B 固体药物剂型 The solid pharmaceutical dosage form
12/07/2011CN101163466B 2-(2-硝基-4-三氟甲基苯甲酰)-1,3-环己二酮在治疗帕金森病中的用途 2- (2-nitro-4-trifluoromethylbenzoyl) -1,3-cyclohexanedione in the treatment of Parkinson's disease in use
12/07/2011CN101153044B 广谱抗菌的含有硫基噻唑吡啶鎓甲基的头孢烯化合物 Cephem compounds containing thio-thiazol-pyridiniummethyl of broad-spectrum antimicrobial
12/07/2011CN101134026B 长春瑞滨软胶囊及其制备方法和其应用 Vinorelbine soft capsule and its preparation method and its application
12/07/2011CN101121934B 多靶点miRNA反义核苷酸的制备方法 Preparation of multi-target miRNA antisense nucleotides
12/07/2011CN101121021B 人源化抗ErbB2抗体及用抗ErbB2抗体进行的治疗 Humanized anti-ErbB2 antibody treatment with anti-ErbB2 antibody and carried out
12/07/2011CN101102816B 用于治疗肝性脑病的含有鸟氨酸和苯基乙酸(phenylacetate)或苯基丁酸(phenylbutyrate)的组合物 Composition for the treatment of hepatic encephalopathy containing ornithine and phenylacetic acid (phenylacetate) or phenyl butyric acid (phenylbutyrate) of
12/07/2011CN101102795B 用于抑制纤维化的药物载体和药物载体试剂盒 Drug carrier for inhibiting fibrosis and drug carrier kit
12/07/2011CN101084904B 头孢克肟缓释双层片 Cefixime sustained release bilayer tablet
12/07/2011CN101084193B (r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓盐酸盐的晶型 (R) -8- chloro-l-methyl-2,3,4,5-tetrahydro -1h-3- benzazepine hydrochloride crystalline form of
12/07/2011CN101065485B Lna寡核苷酸和癌症治疗 Lna oligonucleotides and cancer treatment
12/07/2011CN101056867B 光学活性的胺衍生物的制备方法 The method for preparing an optically active amine derivative
12/07/2011CN101056632B 用作蛋白激酶抑制剂的化合物和组合物 Compounds and compositions are useful as protein kinase inhibitors
12/07/2011CN101054344B 脂氧素A<sub>4</sub>类似物 Lipoxin A <sub> 4 </ sub> analogue
12/07/2011CN101035522B Dpp-ⅳ抑制剂、ppar抗糖尿病剂和二甲双胍的组合 Dpp-ⅳ inhibitors, antidiabetic agents and metformin combination ppar
12/07/2011CA2742032A1 Compositions and methods for treating myelodysplastic syndrome
12/06/2011USRE43005 Compositions and methods for their preparation from lepidium
12/06/2011USRE43003 Epothilone derivatives
12/06/2011US8073538 Treatment of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart
12/06/2011US8071838 Targeted and regional cellular ablation in zebrafish
12/06/2011US8071818 Therapeutic compounds
12/06/2011US8071807 Antagonists of prostaglandin D2 receptors
12/06/2011US8071797 Heterocyclic antiviral compounds
12/06/2011US8071794 Long wavelength thiol-reactive fluorophores
12/06/2011US8071780 2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
12/06/2011US8071778 Substituted heterocyclic ethers and their use in CNS disorders
12/06/2011US8071777 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
12/06/2011US8071776 Thienopyridines as allosteric potentiators of the M4 muscarinic receptor
12/06/2011US8071774 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/06/2011US8071773 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/06/2011US8071766 HSP90 inhibitors
12/06/2011US8071764 Compounds of reverse turn mimetics and the use thereof (2)
12/06/2011US8071763 Methods for treatment of nocturia
12/06/2011US8071757 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
12/06/2011US8071692 Multi-arm block copolymers as drug delivery vehicles
12/06/2011US8071654 Inhibitors of thromboxane formation and action
12/06/2011US8071653 Use of RR/SR-ractopamine
12/06/2011US8071652 Method of treating irritable bowel syndrome
12/06/2011US8071651 5-amino-4-hydroxy-7-(imidazo [1,2-A] pyridin-6-ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
12/06/2011US8071650 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
12/06/2011US8071649 Method for treatment of nocturia
12/06/2011US8071648 Topical nepafenac formulations
12/06/2011US8071647 Method for treatment of adhesion of the intestines
12/06/2011US8071646 Omega 3 fatty acid formulations
12/06/2011US8071645 Antiinflammatory or antiproliferation agents, wound healing agents for wounds and metabolic agents
12/06/2011US8071644 Combinations of adapalene and benzoyl peroxide for treating acne lesions
12/06/2011US8071643 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
12/06/2011US8071641 Treating or preventing diabetes with cannabidiol
12/06/2011US8071640 Urea oligomers, their preparation process and pharmaceutical compositions containing them
12/06/2011US8071638 Solid states of atorvastatin potassium
12/06/2011US8071637 Dithiolopyrrolones compounds and their therapeutic applications
12/06/2011US8071636 Methods of treating alpha adrenergic mediated conditions
12/06/2011US8071635 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/06/2011US8071633 Pharmaceutical composition for treating spinocerebellar ataxia
12/06/2011US8071632 Antioxidant inflammation modulators: novel derivatives of oleanolic acid
12/06/2011US8071631 An enzyme in the tryptophan degradation pathway, used to treat neurodegenerative disorders, certain cancers, drug addiction; arylsulfonamides such as 3,4-dimethoxy-N-[5-(4-chlorophenyl)-1,2,4-thiadiazole-3-yl]benzenesulfonamide
12/06/2011US8071630 Treatment of effect of chemicals with their ultradilute stereoisomers
12/06/2011US8071628 Indazole derivatives
12/06/2011US8071626 Chelating agents and highly luminescent and stable chelates and their use
12/06/2011US8071625 Certain chemical entities, compositions, and methods
12/06/2011US8071624 N-substituted piperidines and their use as pharmaceuticals
12/06/2011US8071623 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
12/06/2011US8071622 1-[1-(6-Methoxy-1H-indole-2-carbonyl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one; vasopressin receptors antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
12/06/2011US8071621 Alkylsulphonamide quinolines
12/06/2011US8071620 Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
12/06/2011US8071619 Injectable liquid formulation of paracetamol
12/06/2011US8071618 Caspase inhibitors and uses thereof
12/06/2011US8071617 Modulators of cellular adhesion
12/06/2011US8071616 Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
12/06/2011US8071615 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/06/2011US8071614 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
12/06/2011US8071613 Anti-constipation composition
12/06/2011US8071611 Spirocyclic heterocyclic derivatives and methods of their use
12/06/2011US8071609 Unsaturated heterocyclic derivatives
12/06/2011US8071608 Therapeutic agents